Donor Breast Milk 2
for Iron Deficiency Anemia
1 location in Orlando
Sponsor: AdventHealth
Sex: All·Age: 29 Weeks - 33 Weeks
Code: NCT07816601·Recruiting·Listed Sep 11, 2026
Clinical Trials at AdventHealth Orlando
As of September 2026, 61 paid clinical trials are recruiting at AdventHealth Orlando, located at 13800 VETERANS WAY, ORLANDO, FL 32827-7403, phone (866) 793-4591 in Orlando, Florida. Active studies at this site cover conditions such as Obesity, Crohn's Disease and Ovarian Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
Newly added in Orlando
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
62 clinical trials at AdventHealth Orlando
·Clear filters· Get a weekly email when new trials open in Orlando, FL.
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
for Ulcerative Colitis (UC)
Drug: LY4268989
Sites in Orlando, Kissimmee +49 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 80
Code: NCT07415044·Phase 2·Recruiting·Listed Feb 2026
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
for Carcinoma, Transitional Cell
Sites in Orlando +61 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07218380·Phase 3·Recruiting·Listed Oct 2025
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
for Prostatic Neoplasms, Castration-Resistant
Drug: Pasritamig
Sites in Orlando, Sarasota +51 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07225946·Phase 3·Recruiting·Listed Nov 2025
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
for Crohn's Disease
Drug: Duvakitug
Sites in Orlando, Kissimmee +123 more locations
Sponsor: Sanofi
Sex: All·Age: 16 - 80
Code: NCT07184931·Phase 3·Recruiting·Listed Sep 2025
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
for Ovarian Neoplasms
Sites in Orlando, Tampa +84 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07213804·Phase 3·Recruiting·Listed Oct 2025
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for Carcinoma, Non-Small-Cell Lung
Drug: Amivantamab
Sites in Orlando, Tampa +123 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06667076·Phase 2·Recruiting·Listed Oct 2024
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
for Advanced Non-Small Cell Lung Cancer
Drug: Adagrasib
Sites in Orlando, Celebration +190 more locations
Sponsor: Mirati Therapeutics Inc.
Sex: All·Age: 18+
Code: NCT04613596·Phase 2, Phase 3·Recruiting·Listed Nov 2020
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
for Crohn's Disease
Drug: Tulisokibart
Sites in Orlando, Inverness +69 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 16 - 80
Code: NCT06430801·Phase 3·Recruiting·Listed May 2024
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
for Heart Failure With Preserved Ejection Fraction
Sites in Orlando, Winter Park +117 more locations
Sponsor: Amgen
Sex: All·Age: 18 - 99
Code: NCT07037459·Phase 3·Recruiting·Listed Jun 2025
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
for Lumbar Spinal Stenosis
Sites in Orlando, Saint Cloud +2386 more locations
Sponsor: Stryker Instruments
Sex: All·Age: 18+
Code: NCT03072927·Recruiting·Listed Mar 2017
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
for Pancreatic Neuroendocrine Tumor (pNET)
Sites in Orlando, Tampa +38 more locations
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT06943755·Phase 2, Phase 3·Recruiting·Listed Apr 2025
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for Chronic Inflammatory Demyelinating Polyneuropathy
Drug: riliprubart
Sites in Orlando, Bradenton +30 more locations
Sponsor: Sanofi
Sex: All·Age: 18+
Code: NCT06290141·Phase 3·Recruiting·Listed Mar 2024
Assessment of CCM in HF With Higher Ejection Fraction
for Heart Failure
Sites in Orlando, Atlantis +74 more locations
Sponsor: Impulse Dynamics
Sex: All·Age: 18+
Code: NCT05064709·Recruiting·Listed Oct 2021
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
for Lung Transplant Rejection
Sites in Orlando, Tampa +30 more locations
Sponsor: Sanofi
Sex: All·Age: 18+
Code: NCT06082037·Phase 3·Recruiting·Listed Oct 2023
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
for cGVHD
Sites in Orlando, Jacksonville +29 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT05919511·Recruiting·Listed Jun 2023
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
for Carcinoma, Squamous Cell
Sites in Orlando, Tampa +20 more locations
Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Sex: All·Age: 60+
Code: NCT04892173·Phase 3·Recruiting·Listed May 2021
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
for Type 2 Diabetes
Drug: Dulaglutide
Sites in Orlando, Tampa +39 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 10 - 17
Code: NCT06739122·Phase 3·Recruiting·Listed Dec 2024
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
for Ulcerative Colitis
Sites in Orlando, Clermont +44 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT06598943·Phase 2·Recruiting·Listed Sep 2024
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
for Pulmonary Hypertension
Sites in Orlando +36 more locations
Sponsor: Tempus AI
Sex: All·Age: 18+
Code: NCT06911632·Recruiting·Listed Apr 2025
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
for Acute Kidney Injury
Sites in Orlando, Jacksonville +30 more locations
Sponsor: SeaStar Medical
Sex: All·Age: 18+
Code: NCT05758077·Recruiting·Listed Mar 2023
SELUTION 4 De Novo Small Vessel IDE Trial
for Coronary Artery Disease
Sites in Orlando, Trinity +62 more locations
Sponsor: M.A. Med Alliance S.A.
Sex: All·Age: 18+
Code: NCT05946629·Recruiting·Listed Jul 2023
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
for Heart Failure
Drug: CDR132L
Sites in Orlando, Winter Park +23 more locations
Sponsor: Novo Nordisk A/S
Sex: All·Age: 40 - 84
Code: NCT06979362·Phase 2·Recruiting·Listed May 2025
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
for Pulmonary Embolism
Sites in Orlando, Lakeland +53 more locations
Sponsor: Penumbra Inc.
Sex: All·Age: 18+
Code: NCT04798261·Recruiting·Listed Mar 2021
CCM OPEN HF Registry
for Heart Failure
Sites in Orlando, Tampa +26 more locations
Sponsor: Impulse Dynamics
Sex: All·Age: 18+
Code: NCT07112924·Recruiting·Listed Aug 2025
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
for Chronic Graft-Versus-Host Disease (cGVHD)
Sites in Orlando, Tampa +24 more locations
Sponsor: Deciphera Pharmaceuticals, LLC
Sex: All·Age: 18+
Code: NCT06619561·Phase 2·Recruiting·Listed Oct 2024
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
for Metastatic Colorectal Cancer
Drug: Bevacizumab
Sites in Orlando +16 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT06820463·Phase 2·Recruiting·Listed Feb 2025
The PERSEVERE Study
for Pulmonary Embolism
Sites in Orlando, Sarasota +13 more locations
Sponsor: Inari Medical
Sex: All·Age: 18+
Code: NCT06588634·Recruiting·Listed Sep 2024
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
for Colitis Ulcerative
Drug: MK-8690
Sites in Orlando, Inverness +9 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18 - 75
Code: NCT07463183·Phase 2·Recruiting·Listed Mar 2026
A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors
for Advanced-stage Solid Tumors
Sites in Orlando +1 more location
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07223125·Phase 1·Recruiting·Listed Oct 2025
Trial to Visualize the Ureters With Nizaracianine Triflutate in Adults Undergoing Abdominopelvic Surgery
for Injury of Ureter During Surgery (Disorder)
Sites in Orlando, Tampa +3 more locations
Sponsor: Curadel Surgical Innovations, Inc.
Sex: All·Age: 18+
Code: NCT06101745·Phase 2, Phase 3·Recruiting·Listed Oct 2023
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
for Breast Cancer
Sites in Orlando, Altamonte Springs +1087 more locations
Sponsor: NRG Oncology
Sex: Female·Age: 18 - 60
Code: NCT05879926·Phase 3·Recruiting·Listed May 2023
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
for Stage III Colon Cancer
Sites in Orlando, Kissimmee +923 more locations
Sponsor: NRG Oncology
Sex: All·Age: 18+
Code: NCT05174169·Phase 2, Phase 3·Recruiting·Listed Dec 2021
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
for Pancreatic Acinar Cell Carcinoma
Drug: Olaparib
Sites in Orlando, Altamonte Springs +256 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT04858334·Phase 2·Recruiting·Listed Apr 2021
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
for Advanced Esophageal Adenocarcinoma
Drug: Nivolumab
Sites in Orlando, Miami Beach +328 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT06203600·Phase 2, Phase 3·Recruiting·Listed Jan 2024
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
for Muscle Invasive Bladder Urothelial Carcinoma
Sites in Orlando, Gainesville +441 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT05987241·Phase 2, Phase 3·Recruiting·Listed Aug 2023
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
for Anatomic Stage II Breast Cancer AJCC v8
Sites in Orlando, Ocoee +777 more locations
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 18+
Code: NCT05812807·Phase 3·Recruiting·Listed Apr 2023
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
for Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Drug: Nivolumab
Sites in Orlando, Tampa +382 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 5 - 60
Code: NCT05675410·Phase 3·Recruiting·Listed Jan 2023
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
for Childhood Extracranial Germ Cell Tumor
Sites in Orlando, Tampa +380 more locations
Sponsor: Children's Oncology Group
Sex: All·Age: All ages
Code: NCT03067181·Phase 3·Recruiting·Listed Mar 2017
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
for Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma
Sites in Orlando, Tampa +324 more locations
Sponsor: NRG Oncology
Sex: All·Age: 18+
Code: NCT06958328·Phase 3·Recruiting·Listed May 2025
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
for Hematopoietic and Lymphatic System Neoplasm
Sites in Orlando, Tampa +189 more locations
Sponsor: Children's Oncology Group
Sex: Female·Age: Up to 39
Code: NCT06513962·Phase 3·Recruiting·Listed Jul 2024
Common conditions studied in Orlando
- Obesity (15 active studies)
- Crohn's Disease (14 active studies)
- Ovarian Cancer (14 active studies)
- Endometrial Cancer (13 active studies)
- Ulcerative Colitis (13 active studies)
- Breast Cancer (12 active studies)
Leading research sponsors in Orlando
- Eli Lilly and Company
- University of Central Florida
- AstraZeneca
- Children's Oncology Group
- AbbVie
Frequently asked questions
How many paid clinical trials are currently recruiting in Orlando?
There are approximately 714 recruiting clinical trials in Orlando, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Orlando pay participants?
Most recruiting trials in Orlando compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Orlando?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Orlando?
The most common conditions under active study in Orlando include Obesity (15), Crohn's Disease (14), Ovarian Cancer (14), Endometrial Cancer (13), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Orlando?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Orlando on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Orlando?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Orlando?
Recruiting research sites in Orlando include AdventHealth Orlando, Nemours Children's Hospital, Arnold Palmer Hospital for Children, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Orlando right now?
The largest active categories in Orlando are Cancer & tumors (189), Diabetes & metabolic (48), Neurology & pain (42). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of AdventHealth Orlando?
AdventHealth Orlando is located at 13800 VETERANS WAY, ORLANDO, FL 32827-7403. Use the Google Maps link in the intro above to get directions.
How do I contact AdventHealth Orlando?
You can reach AdventHealth Orlando by phone at (866) 793-4591. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.
Browse more clinical trials
Other cities in Florida
Miami, FL(1,353)Tampa, FL(1,057)Jacksonville, FL(933)Gainesville, FL(548)St. Petersburg, FL(228)Hollywood, FL(212)Sarasota, FL(197)Fort Myers, FL(169)Fort Lauderdale, FL(156)Miami Lakes, FL(155)West Palm Beach, FL(154)Coral Gables, FL(146)Plantation, FL(138)Hialeah, FL(135)Boca Raton, FL(128)Clearwater, FL(114)Pensacola, FL(106)Weston, FL(101)Winter Park, FL(101)Naples, FL(95)Miami Beach, FL(94)Maitland, FL(87)Doral, FL(86)Ocala, FL(82)Bradenton, FL(80)Aventura, FL(79)Pembroke Pines, FL(77)Tallahassee, FL(76)Tamarac, FL(72)Lakeland, FL(70)Coral Springs, FL(65)Deerfield Beach, FL(65)Brandon, FL(60)Daytona Beach, FL(54)Kissimmee, FL(54)Margate, FL(54)Orange City, FL(49)Clermont, FL(42)The Villages, FL(42)Homestead, FL(41)Port Charlotte, FL(41)Jupiter, FL(40)Port Orange, FL(39)Altamonte Springs, FL(37)Largo, FL(37)New Port Richey, FL(37)North Miami, FL(34)DeLand, FL(33)Delray Beach, FL(33)Boynton Beach, FL(31)Saint Augustine, FL(31)Lady Lake, FL(30)Palmetto Bay, FL(29)Atlantis, FL(28)Miami Gardens, FL(28)Miramar, FL(28)Ocoee, FL(27)Bonita Springs, FL(25)Cutler Bay, FL(25)Stuart, FL(24)